179 related articles for article (PubMed ID: 30787100)
1. Time Course of Aldehyde Oxidase and Why It Is Nonlinear.
Abbasi A; Paragas EM; Joswig-Jones CA; Rodgers JT; Jones JP
Drug Metab Dispos; 2019 May; 47(5):473-483. PubMed ID: 30787100
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde oxidase activity in fresh human skin.
Manevski N; Balavenkatraman KK; Bertschi B; Swart P; Walles M; Camenisch G; Schiller H; Kretz O; Ling B; Wettstein R; Schaefer DJ; Pognan F; Wolf A; Litherland K
Drug Metab Dispos; 2014 Dec; 42(12):2049-57. PubMed ID: 25249692
[TBL] [Abstract][Full Text] [Related]
3. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
Paragas EM; Humphreys SC; Min J; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2017 Dec; 145():210-217. PubMed ID: 28888950
[TBL] [Abstract][Full Text] [Related]
4. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
Lake BG; Ball SE; Kao J; Renwick AB; Price RJ; Scatina JA
Xenobiotica; 2002 Oct; 32(10):835-47. PubMed ID: 12419014
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.
Choughule KV; Barr JT; Jones JP
Drug Metab Dispos; 2013 Oct; 41(10):1852-8. PubMed ID: 23918666
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions.
Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S
Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic evaluation of substrate inhibition kinetics observed from aldehyde oxidase-catalyzed reactions.
Wang SW; Abdul-Hadi K; Cohen L; Xia CQ
Drug Metab Lett; 2013 Mar; 7(1):2-14. PubMed ID: 24151826
[TBL] [Abstract][Full Text] [Related]
10. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine.
Barnes JP; Yang SM; Thompson TS; Guevarra CM; Pleasant SS; Do TQ; Crouch RD
Drug Metab Dispos; 2023 Jun; 51(6):782-791. PubMed ID: 36921993
[TBL] [Abstract][Full Text] [Related]
12. The Inactivation of Human Aldehyde Oxidase 1 by Hydrogen Peroxide and Superoxide.
Garrido C; Leimkühler S
Drug Metab Dispos; 2021 Sep; 49(9):729-735. PubMed ID: 34183377
[TBL] [Abstract][Full Text] [Related]
13. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
Tanoue C; Sugihara K; Tayama Y; Uramaru N; Watanabe Y; Ohta S; Kitamura S
Drug Metab Lett; 2017; 10(4):278-285. PubMed ID: 28029084
[TBL] [Abstract][Full Text] [Related]
14. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.
Behera D; Pattem R; Gudi G
Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630
[TBL] [Abstract][Full Text] [Related]
15. Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.
Dalvie D; Xiang C; Kang P; Zhou S
Xenobiotica; 2013 May; 43(5):399-408. PubMed ID: 23046389
[TBL] [Abstract][Full Text] [Related]
16. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
[TBL] [Abstract][Full Text] [Related]
17. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of rabbit aldehyde oxidase for nitroguanidine and nitromethylene neonicotinoid insecticides.
Dick RA; Kanne DB; Casida JE
Chem Res Toxicol; 2006 Jan; 19(1):38-43. PubMed ID: 16411654
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of xenobiotics by aldehyde oxidase.
Dalvie D; Zientek M
Curr Protoc Toxicol; 2015 Feb; 63():4.41.1-4.41.13. PubMed ID: 25645247
[TBL] [Abstract][Full Text] [Related]
20. Inter-species variation in the metabolism and inhibition of N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase.
Schofield PC; Robertson IG; Paxton JW
Biochem Pharmacol; 2000 Jan; 59(2):161-5. PubMed ID: 10810450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
